ESC Premium Access

Left atrial remodelling in hypertrophic cardiomyopathy, contributing factors and associated outcomes

Congress Session

About the speaker

Doctor Sarah Cuddy

Brigham and Women's Hospital, Boston (United States of America)
4 presentations
0 follower

5 more presentations in this session

Efficacy and safety of non-vitamin K oral anticoagulants in hypertrophic cardiomyopathy with non-valvular atrial fibrillation: a nationwide cohort study

Speaker: Doctor P. Yang (Seongnam, KR)

Thumbnail

Impact of left atrial enlargement on very long-term outcomes in patients with hypertrophic cardiomyopathy

Speaker: Doctor Y. Azumi (Urayasu, JP)

Thumbnail

Is atrial fibrillation associated with increased mortality in hypertrophic cardiomyopathy? Results from the portuguese registry.

Speaker: Doctor A. Lebreiro (Porto, PT)

Thumbnail

Atrial fibrillation in hypertrophic cardiomyopathy: clinical implications of an early detection through implanted cardioverter defibrillator

Speaker: Doctor R. Morgagni (Rome, IT)

Thumbnail

Microvascular coronary disease and myocardial fibrosis within the spectrum of hypertrophic cardiomyopathy: a histopathologic study.

Speaker: Doctor A. Foa (Bologna, IT)

Thumbnail

Access the full session

Atrial fibrillation in hypertrophic cardiomyopathy

Speakers: Doctor S. Cuddy, Doctor P. Yang, Doctor Y. Azumi, Doctor A. Lebreiro, Doctor R. Morgagni...
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk